2-[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acid → 2-[4-Chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(2-phenylethyl)-1,3-thiazol-2-yl]piperidin-1-yl}propan-1-one
반응식
Cl.[C:2]1([CH2:8][CH2:9][C:10]2[N:11]=[C:12]([CH:15]3[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]3)[S:13][CH:14]=2)[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[Cl:21][C:22]1[C:23]([C:33]([F:36])([F:35])[F:34])=[N:24][N:25]([CH:28]([CH3:32])[C:29](O)=[O:30])[C:26]=1[CH3:27]>>[Cl:21][C:22]1[C:23]([C:33]([F:35])([F:34])[F:36])=[N:24][N:25]([CH:28]([CH3:32])[C:29]([N:18]2[CH2:19][CH2:20][CH:15]([C:12]3[S:13][CH:14]=[C:10]([CH2:9][CH2:8][C:2]4[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=4)[N:11]=3)[CH2:16][CH2:17]2)=[O:30])[C:26]=1[CH3:27]참가 물질
3
반응물 2
생성물 1
실험 절차
4-[4-(2-Phenylethyl)-1,3-thiazol-2-yl]piperidine hydrochloride (II-1, 309 mg) is reacted analogously to Example I-63 with 2-[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acid (282 mg). After chromatographic purification, this gives 2-[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(2-phenylethyl)-1,3-thiazol-2-yl]piperidin-1-yl}propan-1-one (165 mg).
후처리
- customAfter chromatographic purification
출처 및 근거
- ORD 기록
- ord-a487b60aeb264923ab8893024ca8c473
- 출처 데이터셋
- uspto-grants-2011_05
- 특허 번호
- US07943774B2
반응 노트
불러오는 중…